Effect of Dapagliflozin on Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus: Insights from the DECLARE-TIMI 58 Trial

Thomas A. Zelniker, Marc P. Bonaca, Remo H.M. Furtado, Ofri Mosenzon, Julia F. Kuder, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John P.H. Wilding, Andrzej Budaj, Robert G. Kiss, Francisco Padilla, Ingrid Gause-Nilsson, Anna Maria Langkilde, Itamar Raz, Marc S. Sabatine, Stephen D. Wiviott

Research output: Contribution to journalArticlepeer-review

234 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of Dapagliflozin on Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus: Insights from the DECLARE-TIMI 58 Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences